
Cravihenz Tablet
Marketer
Biokindle Lifesciences Pvt Ltd
Salt Composition
Megestrol (160mg)
Overview Cravihenz Tablet
Palbociclib tablets are indicated for the management of hormone receptor-positive breast cancer and endometrial cancer. This medication is particularly effective in cancers responsive to hormonal therapies. Additionally, it may be prescribed to address decreased appetite and unintentional weight loss associated with advanced cancers or HIV infection. Dosage and duration of Palbociclib therapy should be determined and monitored by your physician. Administration with or without food is acceptable, but consistent timing is recommended. Continue treatment as directed by your healthcare provider. Commonly reported adverse effects include increased appetite and weight, dyspnea, vasomotor flushes (facial and neck warmth), hypertension, and constipation. Many of these effects are transient and resolve with continued treatment. Report any persistent or bothersome side effects to your doctor; management strategies may be available. Complete disclosure of all medications currently being used is crucial, as interactions may diminish Palbociclib's efficacy or alter its effects. This medication is contraindicated during pregnancy and lactation. Regular blood tests to assess hormone and glucose levels are usually recommended during treatment.
Uses of Cravihenz Tablet
Cancers of the breast and uterine lining
Major Benefits of Cravihenz Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cravihenz Tablet can be administered with or without food, though consistent timing is recommended.
Common Side effects of Cravihenz Tablet:
- Increased appetite
- Weight gain
- Hot flashes
- High blood pressure
- Constipation
How to use Cravihenz Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cravihenz Tablet can be consumed with or without food, though consistent timing is recommended.
How Cravihenz Tablet works:
Cravihenz tablets contain a progestin, a type of female hormone. This medication modifies hormone levels in women with breast or endometrial cancer, thereby hindering cancer cell proliferation. A common side effect is weight gain, often attributed to increased appetite.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cravihenz Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Use of Cravihenz Tablet is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in both animal and human studies has revealed substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
Use of Cravihenz Tablet while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Cravihenz Tablet.
KidneyCAUTION
Patients with severe renal impairment should exercise caution when using Cravihenz tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Cravihenz Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cravihenz Tablet :
NA
Facts to Know About Cravihenz Tablet
| Label | Value |
|---|---|
| Chemical Type | Progestins |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
